Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Fri Dec 12, 3:25PM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 877-415-3179, participant passcode 30119869.
BASI: 2.16 (-0.02)
BASi's Culex(R) L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
Business Wire - Tue Dec 02, 9:56AM CST
For nearly 15 years, the Culex(R) Automated Blood Sampling systems have allowed researchers to collect better data from non-stressed subjects. The cutting edge system saves time, saves money and saves lives by streamlining the drug discovery process and answering complicated questions at very early stages in research. Now, Bioanalytical Systems, Inc. (NASDAQ:BASI) has expanded that offering to a growing segment of drug discovery research utilizing swine as a research model.
BASI: 2.16 (-0.02)
Bioanalytical Systems (BASI) Upgraded From Sell to Hold
at The Street - Tue Nov 11, 8:08AM CST
Bioanalytical Systems (BASI) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
BASI: 2.16 (-0.02)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 16.77 (-0.28), HBNK: 20.01 (-0.22), BRDR: 9.26 (+0.19), SAPE: 24.83 (+0.01), TAIT: 1.17 (+0.11), BASI: 2.16 (-0.02), GERN: 3.24 (+0.01), NYMX: 0.33 (-0.05), MTEX: 28.10 (-1.00), CKEC: 26.46 (-0.09), ALQA: 4.01 (-0.14)
BASi Names Connie Dougherty Vice President Business Development
Business Wire - Tue Sep 16, 2:02PM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Connie Dougherty as Vice President of Business Development reporting to BASi President and Chief Executive Officer Jacqueline Lemke. She will provide leadership to drive BASi's growth initiatives and efforts to expand the Company's footprint.
BASI: 2.16 (-0.02)
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
A: 39.72 (-0.90), OSIR: 12.92 (-0.04), ILMN: 184.30 (-2.53), LMNX: 17.94 (-0.29), AFFX: 8.94 (-0.36), QGEN: 22.95 (-0.29), BCOR: 13.16 (-0.06), ACCL: 12.51 (+0.03), ABT: 43.69 (-0.77), INCY: 74.65 (-1.27), BMY: 58.75 (-0.93), WAT: 111.56 (-1.80), ISIS: 62.32 (+0.45), SIAL: 136.00 (-0.09), BASI: 2.16 (-0.02), MRK: 57.72 (-1.62), CGEN: 8.27 (+0.14), CRL: 62.66 (-0.32), CELGZ: 3.51 (-0.03), NVS: 93.52 (-0.82)
CORRECTING and REPLACING BASi Reports Third Quarter Net Income of $.03 Per Share
Business Wire - Thu Aug 14, 8:12AM CDT
In the "Earnings Conference Call" paragraph of the release, the second sentence should read: To participate in the call, dial 866.515.2912, passcode #12839680 at least five minutes before the start of the call.
BASI: 2.16 (-0.02)
BASi Reports Third Quarter Net Income of $.03 Per Share
Business Wire - Thu Aug 14, 7:00AM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the third quarter and first nine months of fiscal 2014.
BASI: 2.16 (-0.02)
Bioanalytical Systems to Release Third Quarter Fiscal 2014 Results on Thursday August 14, 2014; Conference Call & Webcast Set for 11:00 a.m. EDT
GlobeNewswire - Wed Aug 06, 12:00PM CDT
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the third quarter of fiscal 2014 ended June 30, 2014 at approximately 8:30 a.m. EDT on Thursday, August 14, 2014. BASi has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter. To participate in the call, dial 866.555.2912, passcode #12839680.
BASI: 2.16 (-0.02)
BASi Names Jeffrey Potrzebowski CFO and James Bourdage VP Bioanalytical Operations
Business Wire - Thu Jun 12, 7:01AM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S. Bourdage, Ph.D., as Vice President Bioanalytical Operations.
BASI: 2.16 (-0.02)
BASi Reports First Quarter Results
Business Wire - Thu Feb 13, 7:00AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter of fiscal 2014.
PRU: 86.66 (-3.13), BASI: 2.16 (-0.02)
Bioanalytical Systems to Release First Quarter Fiscal 2014 Results on Thursday, February 13, 2014; Conference Call & Webcast Set for 11:00 a.m. EST
GlobeNewswire - Wed Feb 05, 7:00AM CST
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the first quarter of fiscal 2014 ended December 31, 2013 at approximately 8:30 a.m. EST on Thursday, February 13, 2014. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 800 299.9630, passcode #66359984.
BASI: 2.16 (-0.02), PHM.VN: 0.700 (+0.020)